Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients

Clinical trial NCT05433350 · COMPLETED

Trial details

NCT number: NCT05433350
Sponsor: Drugs for Neglected Diseases
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Trypanosomiasis, African Trypanosoma Brucei Gambiense; Infection Sleeping Sickness

Start date: 2022-07-09
Primary completion: 2026-03-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.